New Delhi: Information is being received that Covaxin is no longer in clinical trial mode. Consent letter will no longer be necessary for its vaccination. The Subject Expert Committee, which ...
New Delhi: A research paper published in the famous medical science research journal Lancet states that covid vaccine made in India is safe but an analysis of the effectiveness of ...
New Delhi: Bharat Biotech has released the third phase data. The company has claimed 81% Efficiency (Effectiveness). According to the company, 25800 participants were included in the third phase. On ...
The COVAX initiative for equitable global access to COVID-19 vaccines has published its first distribution list, planning enough doses for dozens of countries to immunise more than 3 percent of ...
New Delhi: Covaxin has been accorded approval for restricted emergency use in the country by the Drugs Controller General of India (DCGI) on January 3. Covaxin - vaccine developed by ...
Hyderabad: The Hyderabad-based vaccine-maker, in a fact sheet for recipients and caregivers, said that even pregnant and nursing women should not take the vaccine. People who have taken another Covid-19 ...
New Delhi: Bharat Biotech has developed covaxine in association with the Indian Council of Medical Research (ICMR). Bharat Biotech (BBIL) has received orders from the Government of India for the ...
Politicians apart experts concerns should also be considered. Ubaidullah Nasir It is heartening the scientists have finally succeeded in preparing a vaccine to control the Covid 19 virus.In India the ...
New Delhi:Bharat Biotech, which has been accorded Emergency Use Authorisation from the drug regulator for its COVID-19 vaccine Covaxin, on Monday said they are setting up four vaccine manufacturing facilities ...
New Delhi: Covaxin has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR). The Subject Expert Committee (SEC) on COVID-19 of the Central ...
